Table 1 Baseline characteristics of 30 studies included in a meta-analysis undertaken to explore the rate human immunodeficiency virus (HIV) and tuberculosis (TB) co-infection in China
No. | First author, year | Study period | Study design | Study setting | Region (province/ autonomous region) | Sample size | HIV/TB co-infection | Prevalence | Detection rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Bao, 2010 [26] | 2007.10-2008.10 | Cross-sectional | Population-based | Hunan | 2139 | 94 | 4.39% | - |
2 | Cao, 2021 [55] | 2014.1.1-2019.12.31 | Cross-sectional | Hospital-based | Anhui | 2084 | 24 | 1.15% | 97.52% |
3 | Chen, 2009 [27] | 2007 | Cross-sectional | Population-based | Zhejiang | 577 | 33 | 5.72% | 91.44% |
4 | Chen, 2017 [54] | 2012.10-2013.8 | Cross-sectional | Population-based | Guangxi | 2987 | 143 | 4.80% | 99.5% |
5 | Cheng, 2011 [28] | 2006.9-2007.2 | Cross-sectional | Hospital-based | Henan, Yunnan, Sichuan and Guangxi | 3897 | 250 | 6.44% | - |
6 | Chu, 2010 [29] | 2007 | Cross-sectional | Population-based | Henan | 390 | 7 | 1.79% | 100% |
7 | Cui, 2022 [52] | 2019–2021 | Cohort | Hospital-based | Guangxi | 4539 | 36 | 0.80% | 100% |
8 | Feng, 2013 [31] | 2007.1-2010.12 | Cross-sectional | Population-based | Hubei | 381 | 37 | 9.71% | 86.8% |
9 | He, 2014 [32] | 2007.1.31-2012.12.31 | Cross-sectional | Hospital-based | Guangxi | 2377 | 96 | 4.04% | - |
10 | Huang, 2014 [33] | 2007–2011 | Cross-sectional | Population-based | Jiangxi | 1659 | 105 | 6.33% | 95% |
11 | Li, 2010 [34] | 2007.1.1-2010.6.30 | Cross-sectional | Population-based | Xinjiang | 19,453 | 2104 | 10.82% | 85.34% |
12 | Li, 2015 [35] | 2012–2014 | Cross-sectional | Hospital-based | Xinjiang | 1195 | 91 | 7.60% | 83% |
13 | Liu, 2014 [36] | 2007–2011 | Cross-sectional | Population-based | Hubei | 404 | 5 | 1.24% | 100% |
14 | Lv, 2019 [37] | 2011.1-2017.12 | Case–control | Hospital-based | Sichuan | 1366 | 127 | 9.30% | 100% |
15 | Mai, 2017 [51] | 2006.11-2011.12 | Cross-sectional | Hospital-based | Xinjiang | 3032 | 333 | 11% | 100% |
16 | Mei, 2010 [38] | 2007–2008 | Cross-sectional | Population-based | Henan | 390 | 50 | 12.82% | 94.36% |
17 | Nie, 2018 [56] | 2004–2015 | Case–control | Population-based | Chongqing | 19,512 | 1109 | 5.68% | 95.66% |
18 | Pan, 2010 [39] | 2006–2008 | Cross-sectional | Hospital-based | Guizhou | 2709 | 168 | 6.20% | - |
19 | Pan, 2022 [53] | 2015–2020 | Cross-sectional | Population-based | Chongqing | 850 | 46 | 5.41% | 92.79% |
20 | Qian, 2009 [40] | 2007 | Cross-sectional | Hospital-based | Shanxi | 195 | 9 | 4.69% | 83% |
21 | Qu, 2014 [41] | 2007.10-2011.12 | Cross-sectional | Hospital-based | Guangxi | 859 | 71 | 8.27% | 88.65% |
22 | Rong, 2014 [42] | 2007.1-2011.9 | Cross-sectional | Hospital-based | Anhui | 1183 | 27 | 2.28% | 100% |
23 | Wang, 2010 [43] | 2006.9.30-2009.10.1 | Cross-sectional | Population-based | Shandong | 200 | 6 | 3.00% | 97.56% |
24 | Xu, 2009 [44] | 2006.10.1-2008.9.30 | Cross-sectional | Population-based | Guangxi | 10,016 | 1010 | 10.08% | 64.47% |
25 | Xu, 2016 [45] | 2002.12.16-2012.6.30 | Cross-sectional | Population-based | Hunan | 205 | 19 | 9.27% | 97.62% |
26 | Yin, 2012 [46] | 2006.10.1-2010.12.31 | Cross-sectional | Hospital-based | Hubei | 1409 | 21 | 1.49% | 92.64% |
27 | Yin, 2013 [47] | 2011.1-2012.6 | Cross-sectional | Population-based | Guangdong | 208 | 14 | 6.70% | 14.4% |
28 | Yuan, 2015 [48] | 2010–2013 | Cross-sectional | Hospital-based | Guizhou | 6071 | 697 | 11.48% | 86.74% |
29 | Zhang, 2007 [49] | 2006.6-2006.7 | Cross-sectional | Population-based | Shanxi | 390 | 36 | 9.23% | 82.63% |
30 | Zhang, 2015 [50] | 2011–2013 | Cross-sectional | Population-based | Zhejiang | 3534 | 45 | 1.27% | 95.67% |